What is the fair value of Aldeyra The (NASDAQ-ALDX) stock?

The current fair value estimate for Aldeyra The (NASDAQ-ALDX) is $1.78. This implies an estimated upside of 2.4% versus the current market price.

Is Aldeyra The (NASDAQ-ALDX) undervalued or overvalued?

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 2.4% versus the current market price.

What is the analyst price target for NASDAQ-ALDX stock?

The available analyst price target for Aldeyra The (NASDAQ-ALDX) is $7.17. The analyst target implies estimated upside of 313.1%.

How is the financial health of Aldeyra The?

The current financial health read for Aldeyra The (NASDAQ-ALDX) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Aldeyra The's next earnings date?

The next earnings date currently listed for Aldeyra The (NASDAQ-ALDX) is July 31, 2026.

Does Aldeyra The (NASDAQ-ALDX) pay dividends?

Based on the current data, dividend yield is 0.0%.

What is the P/E ratio for Aldeyra The (NASDAQ-ALDX)?

The current P/E ratio listed for Aldeyra The (NASDAQ-ALDX) is -3.8x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

What is the market capitalization of Aldeyra The?

The current market capitalization listed for Aldeyra The is 102.5 M.

What is the enterprise value of Aldeyra The?

The current enterprise value listed for Aldeyra The is 54.866 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Aldeyra The?

The ticker symbol for Aldeyra The is NASDAQ-ALDX, and the stock is listed on NASDAQ.

Where is Aldeyra The (NASDAQ-ALDX) listed?

Aldeyra The (NASDAQ-ALDX) is listed on NASDAQ.

What is the debt-to-total-capital ratio for Aldeyra The?

The current debt-to-total-capital ratio listed for Aldeyra The is 13.1%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Aldeyra The?

The free float listed for Aldeyra The is 87.3%. Free float helps investors understand how much of the share base is available for public trading.

Aldeyra The (ALDX) Fair Value & Stock Analysis

Aldeyra The (ALDX)

Aldeyra Therapeutics, Inc. is a biotechnology company focused on discovering and developing therapies for immune-mediated diseases. Its clinical pipeline is led by reproxalap, a reactive aldehyde species (RASP) modulator being evaluated in Phase III trials for dry eye disease and allergic conjunctivitis. The company also is developing ADX-2191, a dihydrofolate reductase inhibitor under study for primary vitreoretinal lymphoma and retinitis pigmentosa. Another program, ADX-629, is an orally administered RASP modulator in Phase 2 trials for COVID-19, atopic asthma, psoriasis, and alcohol intoxication. Aldeyra also maintains preclinical RASP platforms, including ADX 248, ADX 246, and additional novel modulators. Founded in 2004 and formerly known as Aldexa Therapeutics, the company adopted its current name in March 2014 and is based in Lexington, Massachusetts.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Analyst Target Rating	Overall Financial Health	Upcoming Dividend Ex-Date	Dividend Payment Date	Upcoming Dividend	Dividend Yield	Next Earnings Date	P/E Ratio	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
NASDAQ-ALDX	$1.78	2.4% Upside	Fair	$7.17	313.1% Upside	Bargain	Fair	—	—	—	0.0%	July 31, 2026	-3.8x	2.5x	—	102.5 M	54.866 M	13.1%	87.3%	-8.4	—	94.9%

Send a message